These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31959364)

  • 1. [Mucopolysaccharidosis: A review].
    Michaud M; Belmatoug N; Catros F; Ancellin S; Touati G; Levade T; Gaches F
    Rev Med Interne; 2020 Mar; 41(3):180-188. PubMed ID: 31959364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mucopolysaccharidosis: clinical features, diagnosis and management].
    Suarez-Guerrero JL; Gómez Higuera PJ; Arias Flórez JS; Contreras-García GA
    Rev Chil Pediatr; 2016; 87(4):295-304. PubMed ID: 26613630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidoses seen in adults in rheumatology.
    Mitrovic S; Gouze H; Gossec L; Schaeverbeke T; Fautrel B
    Joint Bone Spine; 2017 Dec; 84(6):663-670. PubMed ID: 28196778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of mucopolysaccharidoses by analyses of the excreted sulfated mucopolysaccharides.
    Cohen DM; Mourão PA; Dietrich CP
    Clin Chim Acta; 1977 Nov; 80(3):555-62. PubMed ID: 144036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidoses - Clinical Spectrum and Frequency of Different Types.
    Cheema HA; Malik HS; Hashmi MA; Fayyaz Z; Mushtaq I; Shahzadi N
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):80-83. PubMed ID: 28292383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening of mucopolysaccharidoses: past, present, and future.
    Arunkumar N; Langan TJ; Stapleton M; Kubaski F; Mason RW; Singh R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    J Hum Genet; 2020 Jul; 65(7):557-567. PubMed ID: 32277174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidoses and the blood-brain barrier.
    Sahin O; Thompson HP; Goodman GW; Li J; Urayama A
    Fluids Barriers CNS; 2022 Sep; 19(1):76. PubMed ID: 36117162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucopolysaccharidoses in children. Experience of a general pediatric service. 11 cases].
    Chaabouni M; Ben Slimen M; Boudawara M; Ben Amar H; Mahfoudh A; Ayadi F; Ben Halima N; Hachicha M; Karaay A; Triki A
    Tunis Med; 2001 Apr; 79(4):222-30. PubMed ID: 11515481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.
    Gabrielli O; Clarke LA; Ficcadenti A; Santoro L; Zampini L; Volpi N; Coppa GV
    BMC Med Genet; 2016 Mar; 17():19. PubMed ID: 26965916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and diagnosis of suspected glaucoma in patients with mucopolysaccharidosis.
    Ashworth J; Flaherty M; Pitz S; Ramlee A
    Acta Ophthalmol; 2015 Mar; 93(2):e111-7. PubMed ID: 25688487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mucopolysaccharidoses and mucolipidoses.
    Kelly TE
    Clin Orthop Relat Res; 1976; (114):116-33. PubMed ID: 131015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mucopolysaccharidosis. Nosology--clinical aspects--therapeutic approaches].
    Beck M
    Monatsschr Kinderheilkd; 1991 Mar; 139(3):120-7. PubMed ID: 1829136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion.
    Guffon N; Journeau P; Brassier A; Leger J; Chevallier B
    Eur J Pediatr; 2019 Apr; 178(4):593-603. PubMed ID: 30740618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report.
    Lamichhane S; Sapkota A; Sapkota S; Adhikari N; Aryal S; Adhikari P
    Ann Med Surg (Lond); 2024 Jan; 86(1):588-593. PubMed ID: 38222696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.